Výsledky léčby gefitinebem (Iressou) u 89 nemocných s pokročilým nemalobuněčným karcinomem plic (NSCLC)
| Title in English | Results of gefitinib (Iressa) treatment of 89 patients with advanced non-small cell lung cancer (NSCLC) |
|---|---|
| Authors | |
| Year of publication | 2005 |
| Type | Article in Proceedings |
| Conference | Edukační sborník |
| MU Faculty or unit | |
| Citation | |
| Field | Pneumology |
| Keywords | non-small cell lung cancer (NSCLC); treatment; gefinitib |
| Description | The results of the first 89 NSCLC patients treated with gefinitib (Iressa)are presented. The treatment started between Feb 2002 and Aug 2004 In Jan 2005, the median survival was 10.3 months in the group with perfomance status 1. In 39% (44 pats) stabilization was achieved, in 8 (9%) partial remission was confirmed. Complete remission occurred in none. Overall, the tolerance of the drug was very good. |
| Related projects: |